Clinical Study
Dynamic Metabolic Changes during the First 3 Months after 90Y-Ibritumomab Tiuxetan Radioimmunotherapy
Table 1
Patient population characteristic.
| Pt | Age at onset (years) | Stage at onset | Number of prior regimens | Age at RIT (years) | Stage at RIT | Days after previous treatment (days) | PET scan | Baseline | 1-week | 4-week | 12-week |
| 1 | 60 | II | 6 | 76 | III | 27 | ◯ | ◯ | n/a | n/a | 2 | 55 | III | 4 | 63 | I | 31 | ◯ | ◯ | ◯ | ◯ | 3 | 48 | II | 3 | 61 | III | 478 | ◯ | ◯ | ◯ | ◯ | 4 | 56 | III | 2 | 59 | I | 68 | ◯ | n/a | ◯ | ◯ | 5 | 70 | III | 3 | 78 | I | 87 | ◯ | n/a | ◯ | ◯ | 6 | 57 | I | 4 | 67 | III | 90 | ◯ | n/a | ◯ | ◯ | 7 | 43 | III | 4 | 56 | I | 143 | ◯ | ◯ | ◯ | ◯ |
|
|
n/a: not available.
|